Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.
Phrontline Biopharma develops biopharmaceutical products to treat cancer through innovative antibody-drug conjugate technology.
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.
Excellergy develops portfolio of trifunctional effector cell response inhibitors (ECRIs) to combat severe allergic diseases.
Nalu Medical is a medical technology company that offers neurostimulation system designed to treat chronic nerve pain.
Yaotang Bio is a biotechnology company focusing on combining LNP delivery and gene editing technology.
Haoxinqing is an online medical service platform focusing on the fields of mental psychology and chronic disease management.
Medtech Technology is a firm that develops innovative ophthalmic medical devices.
LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
PackGene Biotech provides CRO/CDMO services for gene therapy and cell therapy researchers and developers.
KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Xtremity develops a medical device to offer better connection sockets for prosthetics.
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
USCI Medical Laboratory is a national high-tech company that offers genetic testing services.
AnHeart Therapeutics is a developer of innovative pharmaceutical products.
A biotechnology company developing RNA technologies to shape the future of gene therapy
Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.
Decheng Capital has invested in 51 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Decheng Capital's top investment sectors include Biotechnology, Health Care, Medical, Biopharma, Pharmaceutical. The firm invests across 13 different industry categories.
Among tracked funding rounds, ACELYRIN received $300.0M in a Series C round. Decheng Capital's total known invested capital is $3.8B.
Decheng Capital's average investment size is $77.1M across its portfolio of 51 companies.
Recent Decheng Capital portfolio additions include Equillium, Polares Medical, Phrontline Biopharma, Kind Pharmaceutical, Excellergy. These companies were founded in 2020 or later.